Abstract: The present technology provides a method for the effective participation of tissue, for example, amniotic, chorionic, umbilical cord, or a combination thereof to create a flowable suspension for therapeutic purposes. In contrast to other technologies, the present technology does not require cryogenic milling or pre-freezing to harden the tissue for effective particulation and is further capable of preserving the viability of endogenous cell types in contrast to previous methodologies.